EKTAF (Elekta AB) Current Accrued Expense : $0 Mil (As of Jan. 2025)

View and export this data going back to . Start your Free Trial

What is Elekta AB Current Accrued Expense?

Elekta AB's Current Accrued Expense for the quarter that ended in Jan. 2025 was $0 Mil.

Elekta AB Current Accrued Expense Historical Data

The historical data trend for Elekta AB's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elekta AB Current Accrued Expense Chart

Elekta AB Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

Current Accrued Expense

Get a 7-Day Free Trial

Elekta AB Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Current Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Elekta AB Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Elekta AB Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Elekta AB's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Elekta AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elekta AB (OTCPK:EKTAF) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

EKTAY:USA EKTA B:Sweden EKTABs:UK 0O5H:UK EJXB:Germany

Address

Kungstensgatan 18, Box 7593, Stockholm, SWE, SE-103 93

Website

https://www.elekta.com

Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,300 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 30%; Europe, the Middle East, and Africa accounting for 36%; and the Asia-Pacific contributing the remainder.